DHS 75.23(2)(b)1.
1. A multi-dimensional assessment tool that captures behavioral health, physical health, readiness for change, social risk levels and directly correlates risk level to service levels of care based on frequency and intensity of the service.
DHS 75.23(2)(b)2.
2. Proof that the criteria is accepted and utilized within professional organizations in the field of healthcare and allows for consistency of interpretation across settings and providers.
DHS 75.23 Note
Note: Copies of the ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions (published October 24, 2013) are on file in the department's division of care and treatment services and the legislative reference bureau, and may be obtained from ASAM at 11400 Rockville Pike, Suite 200, Rockville, MD 20852, or https://www.asam.org/asam-criteria/text. DHS 75.23(3)
(3)
Level of care transfer. A service that offers more than one level of care under this chapter shall identify in the clinical record which level of care the patient is receiving based on the clinical assessment. When a level of care transfer is completed as indicated by assessment or treatment plan review, the service shall document the level of care transfer in the record and shall thereafter meet the service requirements for the indicated level of care.
DHS 75.23(4)(a)(a) If a patient is receiving services in more than one level of care at a given time, the service shall adhere to all applicable standards for each level of care, and to the level of care standard with the highest requirement when more than one apply.
DHS 75.23(4)(b)
(b) If a patient is receiving services in more than one level of care at a given time, the patient shall be listed on a roster or patient list for each level of care in which they receive services.
DHS 75.23 History
History: CR 20-047: cr.
Register October 2021 No. 790, eff. 10-1-22.
DHS 75.24(1)(a)(a) A service shall complete an initial screening for an individual that presents for services. The screening shall include all of the following:
DHS 75.24(1)(a)1.
1. Sufficient assessment of dimensional risk and severity of need to determine preliminary level of care.
DHS 75.24(1)(a)2.
2. A determination of the patient's needs for immediate services related to withdrawal risk, acute intoxication, overdose risk, induction of pharmacotherapy, or emergency medical needs.
DHS 75.24(1)(b)
(b) A screening is preliminary, and is either confirmed or modified based on completion of the full assessment and ASAM or other department-approved level of care placement criteria.
DHS 75.24(1)(c)
(c) The screening completed under this subsection may be combined with a more comprehensive assessment.
DHS 75.24(2)
(2)
Emergency services. If a need is identified for immediate services related to withdrawal, acute intoxication, overdose, or other reason, the service may initiate treatment prior to completion of the comprehensive assessment or treatment plan. The patient's record for emergency services shall include documentation of all of the following:
DHS 75.24(2)(b)
(b) A consent for services to be received, signed by the patient or the patient's legal guardian.
DHS 75.24(2)(c)
(c) A progress note for all services delivered to the patient.
DHS 75.24(2)(d)
(d) A reason for the initiation of emergency services and a completed initial screening that evaluates biomedical, mental health, and substance use indicators, and guides decision-making regarding the initial level of care placement and referral.
DHS 75.24(3)
(3)
After hours emergency response. A service shall have a written policy and procedure for how the clinic will provide or arrange for, the provision of services to address a patient's behavioral health emergency or crisis during hours when its offices are closed, or when staff members are not available to provide behavioral health services.
DHS 75.24(4)(a)(a) When a patient's pattern of behavior or acute symptoms of a substance use or mental health disorder indicate the likelihood for significant, imminent harm to the individual or others, including affected family members, the service shall develop a safety plan within 24 hours of the contact.
DHS 75.24(4)(b)
(b) The service shall have written policies and procedures that outline the requirements and process for safety planning.
DHS 75.24(5)(a)(a) A service shall have Naloxone on-site at each facility and branch location, to be administered in the event of an opioid overdose.
DHS 75.24(5)(b)
(b) Naloxone medication shall be maintained and unexpired, and shall be stored in an accessible location.
DHS 75.24(5)(c)
(c) The service shall have written policies and procedures for administration of Naloxone by service staff.
DHS 75.24(5)(d)
(d) The service shall train all staff in recognition of overdose symptoms and administration of Naloxone.
DHS 75.24(5)(e)
(e) Administration of Naloxone by the service to any individual shall be documented in the clinical record or in a facility incident report.
DHS 75.24(6)
(6)
Service delivery for intoxicated individuals. A service shall have written policies and procedures regarding clinically-appropriate response and services for individuals that present with symptoms of acute intoxication, withdrawal, or at risk of withdrawal. The policies and procedures shall include the following:
DHS 75.24(6)(a)
(a) The process for obtaining medical consultation, when indicated.
DHS 75.24(6)(b)
(b) The process for admitting the patient to a higher level of care, withdrawal management service, or direct linkage to medical services, when indicated.
DHS 75.24(6)(c)
(c) The process for ensuring the safety of an intoxicated individual or persons experiencing withdrawal, including an individual operating while intoxicated.
DHS 75.24(6)(d)
(d) The process for follow-up and treatment engagement after an intervention for acute intoxication or withdrawal.
DHS 75.24(7)
(7)
Tobacco use disorder treatment and smoke-free facility. A service shall have written policies outlining the service's approach to assessment and treatment for concurrent tobacco use disorders, and the facility's policy regarding a smoke-free environment.
DHS 75.24(8)
(8)
Culturally and linguistically appropriate services. A service shall have a written policy and procedure for assessing the cultural and linguistic needs of the population to be served, and to ensure that services are responsive and appropriate to the cultural and linguistic needs of the community to be served.
DHS 75.24(9)(a)(a) A service shall have written policies and procedures for intake, including all of the following:
DHS 75.24(9)(a)1.
1. A written consent for treatment, which shall be signed by the prospective patient before admission is completed.
DHS 75.24(9)(a)2.
2. Information concerning communicable illnesses, such as sexually transmitted infections, hepatitis, tuberculosis, and HIV, and shall refer patients with communicable illness for treatment when appropriate.
DHS 75.24(9)(a)4.
4. A method for informing the patient about, and obtaining the patient's signed acknowledgment of having been informed and understanding all of the following:
DHS 75.24(9)(a)4.b.
b. Patient rights and the protection of privacy provided by confidentiality laws.
DHS 75.24(9)(a)4.c.
c. Service regulations governing patient conduct, the types of infractions that result in corrective action or discharge from the service, and the process for review or appeal.
DHS 75.24(9)(a)4.f.
f. Information about the cost of treatment, who will be billed, and the accepted methods of payment if the patient will be billed.
DHS 75.24(9)(a)4.g.
g. Sources of collateral information that may be used for screening and assessment.
DHS 75.24(9)(b)
(b) If the patient is seeking treatment related to opioid use, and the service does not provide medication-assisted treatment for patients with opioid use disorders, the service shall provide information about the benefits and effectiveness of medication as an effective treatment for opioid use disorders. If the patient is not already receiving medication treatment, the service shall obtain the patient's written consent to participate in non-medication treatment, shall provide a referral to a service that offers medication-assisted treatment for opioid use disorders.
DHS 75.24(10)(a)(a) A service shall prioritize admission in the following order:
DHS 75.24(10)(b)
(b) When a waitlist exists for services for pregnant women, the service shall either initiate interim services or notify the department within 2 business days.
DHS 75.24(10)(c)
(c) When a waitlist exists for services for individuals who inject drugs, the service shall either initiate interim services or notify the department within 14 business days.
DHS 75.24(11)(a)(a) Clinical staff of a service, operating within the scope of their knowledge and practice, shall assess each patient through interviews, information obtained during intake, counselor observation, and collateral information.
DHS 75.24(11)(b)
(b) The service shall promote assessments that are trauma-informed.
DHS 75.24(11)(c)
(c) If a comprehensive clinical assessment has been conducted by a referring substance use treatment service and is less than 90 days old, the assessment may be utilized in lieu of conducting another one.
DHS 75.24(11)(d)
(d) Information for the assessment shall include the following:
DHS 75.24(11)(d)1.
1. The clinical staff's evaluation of the patient, and documentation of psychological, social, and physiological signs and symptoms of substance use and/or mental health disorders, based on criteria in the DSM.
DHS 75.24(11)(d)2.
2. The summarized results of all psychometric, cognitive, vocational, and physical examinations provided as part of the assessment.
DHS 75.24(11)(d)4.
4. Documentation about the current mental and physical health status of the patient.
DHS 75.24(11)(d)5.
5. Psychosocial history information shall include all of the following areas that relate to the patient's presenting problem:
DHS 75.24(11)(d)5.i.
i. Other factors that appear to have a relationship to the patient's substance use and physical and mental health.
DHS 75.24(11)(d)6.
6. The clinical assessment shall include any collateral information gathered during the clinical assessment. Collateral information may include one of more of the following:
